Laney Robinson
Family Medicine · Paris, ILNPI 1750874087
Payments from drug & device makers
Across 178 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$649
- GSK$475
- Amgen$391
- Novartis$321
- Pfizer$234
- Johnson & Johnson$194
- plus $612 from 14 others
What the payments were for
- Food & beverage$2,876100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $649 |
| GSK | 38 | $475 |
| Amgen | 32 | $391 |
| Novartis | 23 | $321 |
| Pfizer | 13 | $234 |
| Johnson & Johnson | 11 | $194 |
| Dexcom, Inc. | 5 | $109 |
| Exact Sciences | 6 | $101 |
| Novo Nordisk | 6 | $90 |
| AbbVie | 3 | $62 |
| Mylan Specialty L.p. | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Irhythm Technologies, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$113
How this compares
$2,876 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $48,908 |
| JardianceEmpagliflozin | 32 | $38,197 |
| EliquisApixaban | 54 | $37,562 |
| TrulicityDulaglutide | 31 | $35,007 |
| OzempicSemaglutide | 37 | $34,671 |
| InvokanaCanagliflozin | 19 | $33,153 |
| MounjaroTirzepatide | 25 | $28,692 |
| FarxigaDapagliflozin Propanediol | 31 | $28,586 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $12,456 |
| LinzessLinaclotide | 18 | $11,885 |
| Bydureon BciseExenatide Microspheres | 11 | $9,047 |
| Atorvastatin Calcium | 458 | $3,670 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 93 | $2,380 |
| Levothyroxine Sodium | 245 | $2,368 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $2,017 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $17 | $63,69956 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $475 | $61,36469 claims |
| Boehringer IngelheimJardiance | $13 | $38,19732 claims |
| PfizerEliquis | $234 | $37,56254 claims |
| Novo NordiskOzempic | $90 | $34,67137 claims |
| Johnson & JohnsonInvokana | $194 | $33,15319 claims |
| AstraZenecaFarxiga | $649 | $28,58631 claims |
| AbbVieLinzess, Synthroid | $62 | $13,36841 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Paris
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.